ATE208425T1 - Kodierende sequenzen des menschlichen brca1-gens - Google Patents

Kodierende sequenzen des menschlichen brca1-gens

Info

Publication number
ATE208425T1
ATE208425T1 AT97907894T AT97907894T ATE208425T1 AT E208425 T1 ATE208425 T1 AT E208425T1 AT 97907894 T AT97907894 T AT 97907894T AT 97907894 T AT97907894 T AT 97907894T AT E208425 T1 ATE208425 T1 AT E208425T1
Authority
AT
Austria
Prior art keywords
brca1
coding sequences
gene
brca1 gene
sequences
Prior art date
Application number
AT97907894T
Other languages
English (en)
Inventor
Patricia D Murphy
Antonette C Allen
Christopher P Alvares
Brenda S Critz
Sheri J Olson
Denise B Schelter
Bin Zeng
Original Assignee
Gene Logic Acquisition Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24396174&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE208425(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gene Logic Acquisition Corp filed Critical Gene Logic Acquisition Corp
Application granted granted Critical
Publication of ATE208425T1 publication Critical patent/ATE208425T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT97907894T 1996-02-12 1997-02-12 Kodierende sequenzen des menschlichen brca1-gens ATE208425T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/598,591 US5654155A (en) 1996-02-12 1996-02-12 Consensus sequence of the human BRCA1 gene
PCT/US1997/003038 WO1997029213A1 (en) 1996-02-12 1997-02-12 Coding sequences of the human brca1 gene

Publications (1)

Publication Number Publication Date
ATE208425T1 true ATE208425T1 (de) 2001-11-15

Family

ID=24396174

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97907894T ATE208425T1 (de) 1996-02-12 1997-02-12 Kodierende sequenzen des menschlichen brca1-gens

Country Status (14)

Country Link
US (2) US5654155A (de)
EP (3) EP1126034A3 (de)
JP (2) JPH11503924A (de)
AT (1) ATE208425T1 (de)
AU (1) AU1977897A (de)
BR (1) BR9702080A (de)
CA (1) CA2218251C (de)
DE (1) DE69707985T2 (de)
DK (1) DK0820526T3 (de)
ES (1) ES2170366T3 (de)
IL (1) IL121926A (de)
IS (1) IS4587A (de)
PT (1) PT820526E (de)
WO (1) WO1997029213A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403303B1 (en) * 1996-05-14 2002-06-11 Visible Genetics Inc. Method and reagents for testing for mutations in the BRCA1 gene
US5747282A (en) * 1994-08-12 1998-05-05 Myraid Genetics, Inc. 17Q-linked breast and ovarian cancer susceptibility gene
US6083698A (en) * 1995-09-25 2000-07-04 Oncormed, Inc. Cancer susceptibility mutations of BRCA1
US6951721B2 (en) * 1996-02-12 2005-10-04 Gene Logic Inc. Method for determining the haplotype of a human BRCA1 gene
US6130322A (en) * 1996-02-12 2000-10-10 Gene Logic, Inc. Coding sequences of the human BRCA1 gene
US5654155A (en) * 1996-02-12 1997-08-05 Oncormed, Inc. Consensus sequence of the human BRCA1 gene
US6838256B2 (en) 1996-02-12 2005-01-04 Gene Logic Inc. Coding sequences of the human BRCA1 gene
US20030022184A1 (en) * 1996-02-12 2003-01-30 Oncormed. Inc. Coding sequences of the human BRCA1 gene
US5891857A (en) * 1996-02-20 1999-04-06 Vanderbilt University Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins
CA2198801A1 (en) * 1996-02-29 1997-08-29 Catherine M. Phelan Method and kit for evaluating risk of ovarian cancer in carriers of brc a1 mutation
NZ333635A (en) * 1996-07-08 2000-06-23 Univ Texas BRCA1 associated proteins and peptides and the nucleotide encoding such proteins
AU4586697A (en) * 1996-09-20 1998-04-14 Board Of Regents, The University Of Texas System Compositions and methods comprising bard1 and other brca1 binding proteins
AU5093898A (en) * 1996-10-31 1998-05-22 Jennifer Lescallett Primers for amplification of brca1
US6048689A (en) * 1997-03-28 2000-04-11 Gene Logic, Inc. Method for identifying variations in polynucleotide sequences
EP0878552A1 (de) * 1997-05-13 1998-11-18 Erasmus Universiteit Rotterdam Molekularer Nachweis von chromosomalen Veränderungen
WO1999006598A2 (en) * 1997-08-04 1999-02-11 Oncormed, Inc. Determining common functional alleles in a population and uses therefor
US20090269814A1 (en) * 1998-05-22 2009-10-29 Murphy Patricia D Method of Analyzing a BRCA2 Gene in a Human Subject
AU9586598A (en) * 1997-09-23 1999-04-12 Oncormed, Inc. Genetic panel assay for susceptibility mutations in breast and ovarian cancer
US6492109B1 (en) 1997-09-23 2002-12-10 Gene Logic, Inc. Susceptibility mutation 6495delGC of BRCA2
US6030832A (en) 1997-11-21 2000-02-29 Myriad Genetics, Inc. Carboxy-terminal BRCA1 interacting protein
US6177410B1 (en) 1997-12-05 2001-01-23 Vanderbilt University Therapeutic methods for prostate cancer
US6897018B1 (en) 1998-02-25 2005-05-24 The United States Of America As Represented By The Department Of Health And Human Services DLC-1 gene deleted in cancers
WO1999057309A1 (en) * 1998-05-04 1999-11-11 Dako A/S Method and probes for the detection of chromosome aberrations
US6686163B2 (en) * 1998-05-06 2004-02-03 Gene Logic Inc. Coding sequence haplotype of the human BRCA1 gene
AU771224B2 (en) 1998-07-13 2004-03-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
EP1234585A3 (de) 1998-09-04 2004-01-21 The Regents Of The University Of Michigan Zusammensetzungen zur Vorbeugung oder Behandlung von Krebs
US20030180789A1 (en) * 1998-12-30 2003-09-25 Dale Roderic M.K. Arrays with modified oligonucleotide and polynucleotide compositions
US6087112A (en) * 1998-12-30 2000-07-11 Oligos Etc. Inc. Arrays with modified oligonucleotide and polynucleotide compositions
AU2003243357A1 (en) * 2002-06-06 2003-12-22 Johns Hopkins University School Of Medicine Allelic variation in human gene expression
EP2269656B1 (de) 2002-07-15 2014-08-20 Board Of Regents, The University Of Texas Ausgewählte antikörper mit bindung an aminophospholipide und ihre verwendung bei der behandlung von krebs
TWI304321B (en) 2002-12-27 2008-12-11 Toray Industries Layered products, electromagnetic wave shielding molded articles and method for production thereof
WO2005061728A1 (en) * 2003-12-16 2005-07-07 Institut Curie Methods and compositions for assaying mutations in nucleic acids
KR20170102377A (ko) 2004-01-22 2017-09-08 유니버시티 오브 마이애미 국소용 코-엔자임 큐10 제형 및 그의 사용 방법
EP2136831B1 (de) 2007-03-02 2012-09-12 The Cleveland Clinic Foundation Anti-angiogene peptide
WO2009060198A1 (en) 2007-11-09 2009-05-14 Peregrine Pharmaceuticals, Inc. Anti-vegf antibody compositions and methods
ES2574137T3 (es) * 2008-09-03 2016-06-15 Quantumdx Group Limited Estrategias y métodos de detección de ácidos nucleicos mediante biosensores
US8372580B2 (en) 2008-11-21 2013-02-12 Morehouse School Of Medicine BRCA1 function-based cellular assays
WO2013064895A1 (en) 2011-10-31 2013-05-10 Genomic Vision Methods for the detection, visualization and high resolution physical mapping of genomic rearrangements in breast and ovarian cancer genes and loci brca1 and brca2 using genomic morse code in conjunction with molecular combing
WO2014140789A1 (en) 2013-03-15 2014-09-18 Genomic Vision Methods for the detection of breakpoints in rearranged genomic sequences
US10036071B2 (en) 2013-03-15 2018-07-31 Genomic Vision Methods for the detection of sequence amplification in the BRCA1 locus
EP3839974B9 (de) 2019-12-20 2023-05-03 Dynamic Code AB Verfahren zur analyse der wahrscheinlichkeit von krankheiten

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221619A (en) 1977-11-08 1993-06-22 Genentech, Inc. Method and means for microbial polypeptide expression
US4704362A (en) 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
US5583013A (en) 1977-11-08 1996-12-10 Genentech, Inc. Method and means for microbial polypeptide expression
US4458066A (en) * 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US5593840A (en) 1993-01-27 1997-01-14 Oncor, Inc. Amplification of nucleic acid sequences
WO1995019369A1 (en) * 1994-01-14 1995-07-20 Vanderbilt University Method for detection and treatment of breast cancer
US5693473A (en) * 1994-08-12 1997-12-02 Myriad Genetics, Inc. Linked breast and ovarian cancer susceptibility gene
ATE201445T1 (de) * 1994-08-12 2001-06-15 Myriad Genetics Inc Mutationen des mit 17q verbundenen ovarial- und brustkrebs empfindlichkeitsgens
WO1996005308A1 (en) * 1994-08-12 1996-02-22 Myriad Genetics, Inc. Method for diagnosing a predisposition for breast and ovarian cancer
US5654155A (en) * 1996-02-12 1997-08-05 Oncormed, Inc. Consensus sequence of the human BRCA1 gene

Also Published As

Publication number Publication date
DE69707985T2 (de) 2002-10-31
WO1997029213A1 (en) 1997-08-14
IL121926A (en) 2006-08-01
JP2012090627A (ja) 2012-05-17
US5654155A (en) 1997-08-05
BR9702080A (pt) 1999-12-28
AU1977897A (en) 1997-08-28
PT820526E (pt) 2002-05-31
EP0820526A1 (de) 1998-01-28
IL121926A0 (en) 1998-03-10
EP0820526A4 (de) 1998-07-08
DK0820526T3 (da) 2002-03-04
ES2170366T3 (es) 2002-08-01
EP2351854A1 (de) 2011-08-03
EP0820526B1 (de) 2001-11-07
EP1126034A2 (de) 2001-08-22
EP1126034A3 (de) 2001-08-29
US5750400A (en) 1998-05-12
CA2218251C (en) 2010-10-19
CA2218251A1 (en) 1997-08-14
DE69707985D1 (de) 2001-12-13
IS4587A (is) 1997-10-10
JPH11503924A (ja) 1999-04-06

Similar Documents

Publication Publication Date Title
ATE208425T1 (de) Kodierende sequenzen des menschlichen brca1-gens
DK0858467T3 (da) Materialer og fremgangsmåder angående identifikationen og sekventeringen af BRCA2 cancerfölsomhedsgen og anvendelser deraf
FI970514A (fi) 17q:hun liittyvä rinta- ja munasarjasyöpäalttiusgeeni
ATE314482T1 (de) Rekombinante adenoviren-vektor und verfahren zur verwendung
CY1106216T1 (el) 5´ ESTs ΓΙΑ ΜΗ ΙΣΤΟ-ΕΙΔΙΚΕΣ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ
HUP0002095A2 (hu) Vegyületek prosztatarák immunterápiás kezelésére és alkalmazásuk
FI970513A0 (fi) In vivo mutaatiot ja polymorfismit 17q:hun liittyvässä rinta- ja munasarjasyöpäalttiusgeenissä
TR200700740T2 (tr) Nogo genlerinin nükleotid ve protein dizileri ve bunlar bazında yöntemler
ATE309536T1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
DE3587875T2 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
AU2003293141A8 (en) Methods for identifying risk of breast cancer and treatments thereof
NO980203L (no) Varianter av proteinet P53 og den terapeutiske anvendelse derav
ATE307886T1 (de) Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung
EP1100815A4 (de) Von protease typ ii spaltbares peptid
ATE517122T1 (de) Modifizierte cea-nukleinsäure und entsprechende expressionsvektoren
EP0960128A4 (de) In Krebszellen überexprimiertes Genprodukt
ATE207536T1 (de) Nukleotid sequenzen und daraus abgleitete aminosäuresequenzen vom tumorgen int 6
ATE349519T1 (de) Gen beteiligt an v(d)j rekombination und/oder dna reparatur
DK1417308T3 (da) Humant protoonkogen KG-20 og deri kodet protein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner